Table 2 Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genogroups, sequence types, and minimum inhibitory concentrations (MICs, mg/L) of ceftriaxone and cefixime for Neisseria gonorrhoeae (n = 143) isolated in Bishkek, Kyrgyzstan, 2012 and 2017
| NG-MAST (number of isolates) | Number of isolates with MIC (mg/L): | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Genogroups | Sequence types | ESC | ≤0.016 | 0.023 | 0.032 | 0.047 | 0.064 | 0.094 | 0.125 | 0.25 | 0.5 |
| 1751 (21) | 1751 (21) | CFM | 20 | 1 | |||||||
| CRO | 18 | 1 | 1 | 1 | |||||||
| 5488 (12) | 15,952 (7), 10,687 (3), 1597 (1), 15,990 (1) | CFM | 10 | 1 | 1 | ||||||
| CRO | 11 | 1 | |||||||||
| 436 (8) | 1691 (6), 15,964 (1), 15,997 (1) | CFM | 8 | ||||||||
| CRO | 6 | 2 | |||||||||
| 368 (6) | 368 (6) | CFM | 4 | 1 | 1 | ||||||
| CRO | 5 | 1 | |||||||||
| 569 (5) | 569 (5) | CFM | 2 | 1 | 1 | 1 | |||||
| CRO | 3 | 2 | |||||||||
| 807/228/51/25 (5) | 807 (5) | CFM | 5 | ||||||||
| CRO | 3 | 2 | |||||||||
| 972 (4) | 972 (3), 2870 (1) | CFM | 3 | 1 | |||||||
| CRO | 3 | 1 | |||||||||
| 387 (3) | 387 (3) | CFM | 2 | 1 | |||||||
| CRO | 2 | 1 | |||||||||
| 340 (2) | 340 (1), 15,992 (1) | CFM | 1 | 1 | |||||||
| CRO | 1 | 1 | |||||||||
| 807 (2) | 5941 (2) | CFM | 1 | 1 | |||||||
| CRO | 1 | 1 | |||||||||
| 2862/1105 (2) | 2862 (1), 15,979 (1) | CFM | 2 | ||||||||
| CRO | 2 | ||||||||||
|
Non-grouped (72): 15951 (4), 14,617 (3), 15,955 (3), 15,957 (3), 15,961 (3), 15,981 (3), 157 (2), 15,953 (2), 15,954 (2), 15,958 (2), 15,959 (2), 15,960 (2), 15,968 (2), 15,986 (2), 15,989 (2); STs presented by single isolate (35) | CFM | 58 | 1 | 3 | 9 | 1 | |||||
| CRO | 58 | 1 | 1 | 3 | 9 | ||||||